4 results match your criteria: "Hawai'i Medical Center East[Affiliation]"
Hawaii Med J
February 2010
Department of Surgery, Hawai'i Medical Center East and University of Hawai'i, John A. Burns School of Medicine, Honolulu 96813, USA.
Tumors presenting in the inguinal hernia sac are considered to be extremely rare, with the more common neoplasms metastasizing from the gastrointestinal tract, ovary and prostate. We report the case of Mantle cell lymphoma identified in the inguinal hernia sac following hernia repair While the hernia sac appeared normal to the surgeon, evaluation by the pathologist showed subtle gross irregularities, with subsequent histologic and immunochemical diagnosis of Mantle cell lymphoma. Twelve previous cases of a lymphoma diagnosed during hernia repair have been described in the English literature.
View Article and Find Full Text PDFHawaii Med J
June 2009
Transplant Institute, Hawai'i Medical Center-East, Honolulu, HI 96817, USA.
Living-renal transplant (LRT) is the most effective treatment for endstage renal disease (ESRD), and innovative strategies to increase donation are needed. We reviewed our ethnically/culturally diverse program to identify factors that contribute to donors' decision to participate. Records of 110 LRT (related:unrelated = 66:44) and respective donors (1999-2005) were reviewed for demographics, outcome, education, employment, language, religion, and motivation.
View Article and Find Full Text PDFHawaii Med J
March 2009
Transplant Institute, Hawai'i Medical Center-East, Honolulu, HI 96817, USA.
Pacific Islanders currently comprise 35% of all end-stage renal disease patients in Hawai'i but a much smaller proportion of those who undergo renal transplant. The purpose of this study to determine the reasons for such a disparity. In this retrospective review of 207 patients who were referred for renal transplant evaluation, 18.
View Article and Find Full Text PDFHawaii Med J
August 2007
Department of Surgery, Hawai'i Medical Center East, Honolulu, HI 96817, USA.
Purpose: Little is known about other primary neoplasms occurring in patients with hepatocellular cancer (HCC). This team attempted to characterize this cohort of patients to define incidence, risk factors, natural history, and potentially shared etiologies.
Methods: A retrospective analysis from an established, prospective database of patients with HCC during 1991-2004 was used to determine demographic data, risk factors, characteristics of the associated second primary neoplasm, and survival.